Profile data is unavailable for this security.
About the company
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceutical products. The Company is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and metabolic drugs and cardiovascular drugs. Its main products include Kewei, Ertongshu, Oumeining, Xinhaining and Xining.
- Revenue in HKD (TTM)5.95bn
- Net income in HKD1.77bn
- Incorporated2001
- Employees4.89k
- LocationYiChang HEC ChangJiang Pharmaceutical Co LtdZhen An Road No. 368Shangsha Village, Chang'an TownDONGGUAN 443300ChinaCHN
- Phone+86 76 981768866
- Fax+86 76 981768866
- Websitehttp://www.hec-changjiang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ocumension Therapeutics | 333.32m | -346.67m | 4.63bn | 477.00 | -- | 1.32 | -- | 13.88 | -0.5289 | -0.5289 | 0.5084 | 4.29 | 0.103 | 2.40 | 2.48 | 750,711.40 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.88bn | -40.60m | 6.52bn | 2.65k | -- | 1.37 | -- | 3.46 | -0.0044 | -0.0044 | 0.2031 | 0.5096 | 0.1506 | 0.894 | 3.90 | 656,234.80 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.39bn | 699.07m | 6.66bn | 4.01k | 9.53 | 0.8738 | 4.76 | 0.9016 | 0.5458 | 0.5458 | 5.77 | 5.95 | 0.5026 | 0.9881 | 5.22 | 1,801,361.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.74bn | 779.00 | 13.64 | 1.77 | 10.90 | 4.89 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| China Shineway Pharmaceutical Group Ltd | 4.52bn | 1.19bn | 6.84bn | 3.23k | 5.27 | 0.8679 | 4.99 | 1.51 | 1.57 | 1.57 | 5.98 | 9.53 | 0.4476 | 1.28 | 5.26 | 1,314,466.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Consun Pharmaceutical Group Ltd | 2.94bn | 898.46m | 7.17bn | 3.18k | 7.58 | 1.79 | 7.29 | 2.44 | 1.11 | 1.11 | 3.65 | 4.71 | 0.5209 | 2.00 | 12.89 | 940,901.90 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 5.95bn | 1.77bn | 8.39bn | 4.89k | 4.74 | 0.9019 | 4.09 | 1.41 | 2.01 | 2.01 | 6.76 | 10.58 | 0.4272 | 2.50 | 3.74 | 1,288,741.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.27bn | -1.28bn | 8.43bn | 1.56k | -- | 2.24 | -- | 6.63 | -1.06 | -1.06 | 1.05 | 3.11 | 0.1462 | 0.6325 | 1.10 | 783,272.40 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.78bn | 827.63m | 9.86bn | 5.23k | 11.91 | 0.7047 | 5.92 | 1.45 | 0.22 | 0.22 | 1.80 | 3.72 | 0.236 | 2.44 | 3.02 | 1,286,903.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.59bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 103.03 | -- | -18.15 | -- | -- | -- |
| Shanghai Henlius Biotech Inc | 6.06bn | 743.71m | 11.03bn | 3.55k | 14.87 | 3.98 | 9.67 | 1.82 | 1.37 | 1.37 | 11.10 | 5.10 | 0.5764 | 1.90 | 6.82 | 1,665,945.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.27bn | 5.80k | 8.30 | 1.56 | 6.16 | 1.74 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| China Traditional Chinese Med Hldg CoLtd | 18.48bn | 985.51m | 11.38bn | 17.72k | 11.55 | 0.4958 | 5.06 | 0.6158 | 0.1957 | 0.1957 | 3.67 | 4.56 | 0.453 | 1.54 | 1.82 | 1,068,071.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
Data as of Nov 22 2024. Currency figures normalised to YiChang HEC ChangJiang Pharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
5.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 06 Nov 2024 | 15.10m | 2.31% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 6.53m | 1.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.89m | 0.60% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.98m | 0.46% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 2.78m | 0.43% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 1.03m | 0.16% |
| American Century Investment Management, Inc.as of 07 Nov 2024 | 951.01k | 0.15% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2024 | 642.40k | 0.10% |
| China Asset Management (Hong Kong) Ltd.as of 30 Sep 2024 | 498.00k | 0.08% |
| Pennsylvania State Employees' Retirement Systemas of 31 Dec 2023 | 486.20k | 0.07% |
More ▼
Data from 31 Dec 2023 - 08 Nov 2024Source: FactSet Research Systems Inc.
